An array of pharmaceutical pills with the company's logo on the bottle. Eli Lilly and Compnay (NYSE:LLY), known for its diabetes and weight-loss drugs, was mentioned at the time due to a strong ...

An array of pharmaceutical pills with the company's logo on the bottle. For this article ... beating its benchmark by 218 ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly's weekly prescription data for Zepbound is up 354% year over year while Novo Nordisk's Wegovy is up just 61%.